Literature DB >> 16473538

Primary and opportunistic pathogens associated with meningitis in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus.

Claudine Békondi1, Claire Bernede, Noella Passone, Pierre Minssart, Come Kamalo, Didier Mbolidi, Yves Germani.   

Abstract

OBJECTIVE: To determine the causative organisms and characteristics of patients presenting with meningitis in Bangui in order to provide guidance to physicians for case management.
METHODS: Adults with proven or suspected meningitis were enrolled in this prospective study. LABORATORY TESTS: Full blood count, blood chemistry, and HIV tests were performed. Cerebrospinal fluid (CSF) was submitted for routine microbiology, chemistry (glucose, protein), and hematology testing. When classical microbiology analyses were negative, a broad-range bacterial polymerase chain reaction (BRBPCR) was used. RESULTS AND
CONCLUSIONS: Of the 276 patients enrolled, 215 (77.9%) were HIV positive. In HIV-positive patients cryptococcal meningitis (CM) was the most common cause of meningitis (39.1%) followed by pyogenic meningitis (PM) (30.7%), mononuclear meningitis (MM) (28.8%), and tuberculous meningitis (TM) (1.4%). In HIV-negative patients, PM was the most common cause (60.7%) followed by MM (37.7%) and CM (1.6%, one case). In-hospital mortality was higher in HIV-positive patients (73/128 = 57%) compared to those HIV negative (3/18 = 16.7%) (p = 0.001). Streptococcus pneumoniae (n = 26) was the most common bacterial diagnosis, mainly in HIV-positive patients (n = 22, 10.2%). Meningococcal meningitis (14 Neisseria meningitidis of group A and one W135) was diagnosed in nine (4.2%) HIV-positive and six (9.8%) HIV-negative patients. Gram-negative rods were isolated from five HIV-positive and two HIV-negative patients, respectively. The bacteria and fungi involved in meningitis did not display high levels of in vitro resistance. Conventional microbiology techniques failed to detect the causative agent in 55 (53.4%) PM cases. Broad-range bacterial PCR detected DNA from S. pneumoniae in three samples, N. meningitidis in two, Escherichia coli in one, Listeria monocytogenes in two and Staphylococcus aureus in one sample. In the CSF of five (three HIV negative and two HIV positive), PCR products were not identified with the oligonucleotide probes specific for the usual species of bacteria found in CSF, or genera commonly considered potential contaminants of clinical samples. Among the MM cases, 77 (90.5%) probable viral meningitis (54 HIV positive and 23 HIV negative) and eight TM (HIV positive) were suspected.

Entities:  

Mesh:

Year:  2006        PMID: 16473538     DOI: 10.1016/j.ijid.2005.07.004

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  27 in total

Review 1.  TB and HIV in the Central African region: current knowledge and knowledge gaps.

Authors:  S Janssen; M A M Huson; S Bélard; S Stolp; N Kapata; M Bates; M van Vugt; M P Grobusch
Journal:  Infection       Date:  2013-12-06       Impact factor: 3.553

2.  Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis.

Authors:  Joseph N Jarvis; Ann Percival; Sean Bauman; Joy Pelfrey; Graeme Meintjes; G Ntombomzi Williams; Nicky Longley; Thomas S Harrison; Thomas R Kozel
Journal:  Clin Infect Dis       Date:  2011-09-21       Impact factor: 9.079

Review 3.  Methods of rapid diagnosis for the etiology of meningitis in adults.

Authors:  Nathan C Bahr; David R Boulware
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

Review 4.  Defense at the border: the blood-brain barrier versus bacterial foreigners.

Authors:  Nina M van Sorge; Kelly S Doran
Journal:  Future Microbiol       Date:  2012-03       Impact factor: 3.165

5.  Evolution of Cryptococcal Antigen Testing: What is new?

Authors:  Elizabeth Nalintya; Reuben Kiggundu; David Meya
Journal:  Curr Fungal Infect Rep       Date:  2016-04-12

Review 6.  An update on Cryptococcus among HIV-infected patients.

Authors:  T Warkentien; N F Crum-Cianflone
Journal:  Int J STD AIDS       Date:  2010-10       Impact factor: 1.359

7.  Is it possible to differentiate tuberculous and cryptococcal meningitis in HIV-infected patients using only clinical and basic cerebrospinal fluid characteristics?

Authors:  J E Vidal; E J F Peixoto de Miranda; J Gerhardt; M Croda; D R Boulware
Journal:  S Afr Med J       Date:  2017-01-30

8.  Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans.

Authors:  Oliver W Liu; Cheryl D Chun; Eric D Chow; Changbin Chen; Hiten D Madhani; Suzanne M Noble
Journal:  Cell       Date:  2008-10-03       Impact factor: 41.582

Review 9.  Antifungal drug discovery through the study of invertebrate model hosts.

Authors:  R Pukkila-Worley; E Holson; F Wagner; E Mylonakis
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

10.  Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.

Authors:  Joseph N Jarvis; Stephen D Lawn; Monica Vogt; Nonzwakazi Bangani; Robin Wood; Thomas S Harrison
Journal:  Clin Infect Dis       Date:  2009-04-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.